Wei‐Chen Lee

Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage

Chun‐Jen Liu, Po‐Huang Lee, Deng‐Yn Lin et al. · Journal of Hepatology · 2009 · 153 citations

Urology, Surgical Oncology, Hepatology +8

Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection

Li‐Tzong Chen, Miin-Fu Chen, Lung-An Li et al. · Annals of Surgery · 2011 · 129 citations

Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence

Kun‐Ming Chan, Chun‐Yi Tsai, Chun‐Nan Yeh et al. · BMC Gastroenterology · 2018 · 95 citations · Full text

Hepatitis B Virus–DNA Level and Basal Core Promoter A1762T/G1764A Mutation in Liver Tissue Independently Predict Postoperative Survival in Hepatocellular Carcinoma

Chau‐Ting Yeh, Mary So, Jennifer Ng et al. · Hepatology · 2010 · 94 citations

Prognostic Factors after Resection for Hepatocellular Carcinoma in Noncirrhotic Livers: Univariate and Multivariate Analysis

Miin‐Fu Chen, Hsiu‐Pei Tsai, Long‐Bin Jeng et al. · World Journal of Surgery · 2003 · 82 citations